SCHEMBL1600685

SCHEMBL1600685

CC[C@@H](OCc1ccccc1)c1ccc(C(F)(F)F)cc1CN(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.44
CETP P11597 16/20 0.40
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1600334 1.00 TACR1 (0.44) TACR1CETPKCNH2
SCHEMBL1600335 1.00 TACR1 (0.44) TACR1CETPKCNH2
SCHEMBL4736026 0.90 CETP (0.42) TACR1CETP
SCHEMBL1601476 0.88 CETP (0.43) TACR1CETP
SCHEMBL1600339 0.88 CETP (0.43) TACR1CETP
SCHEMBL1600342 0.88 CETP (0.43) TACR1CETP
SCHEMBL1600850 0.86 TACR1 (0.43) TACR1CETP
SCHEMBL1600654 0.86 TACR1 (0.43) TACR1CETP
SCHEMBL1600904 0.86 TACR1 (0.43) TACR1CETP
SCHEMBL4975007 0.84 TACR1 (0.49) TACR1CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919506-B2 Dibenzyl amine compounds and derivatives PFIZER INC. (US) 2011-04-05 US claimed
US-20070213371-A1 Dibenzyl Amine Compounds and Derivatives PFIZER INC 2007-09-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213371-A1 Dibenzyl Amine Compounds and Derivatives APOB, LDLR, CETP TACR1 2334/4885CETP 3/4885KCNH2 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.